ATAI Investor Day Presentation Deck slide image

ATAI Investor Day Presentation Deck

Preliminary evidence for dose-dependent changes in ERP ERPS support physiological differences between acute administration of low and high dose groups RL - 007 may remediate SZ-related deficits in sensory memory at low to moderate doses With this acute treatment there was no consistent response across timepoints Significantly increased MMN amplitudes at the lower dose levels (10 & 20 mg) vs salient decrease in MMN amplitudes at 40 mg ● No effect on P300b at low doses vs sporadic significantly decreased in P300b amplitudes at the highest dose levels (40 & 80 mg) atai LIFE SCIENCES MMN8 trough exposure time-point D2 vs D4-PKAMP (20mg) FZ-LE MMN8_D2_Predose MMN8_D4_Predose μV min -2- 0- 2- 6- -100 -50 0 50 100 150 200 250 300 350 ms ● Mismatch negativity - passive auditory oddball event- related potential (ERP) Salient beneficial changes in MMN amplitude and latency observed in 20 mg cohort 136
View entire presentation